Cantor Fitzgerald Reiterates Overweight on TruBridge, Maintains $24 Price Target
$TBRG
EDP Services
Technology
Cantor Fitzgerald analyst Sarah James reiterates TruBridge (NASDAQ:TBRG) with a Overweight and maintains $24 price target.
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 3/28/2024 | $13.00 | Outperform | RBC Capital Mkts |
TruBridge, Inc. (NASDAQ:TBRG), a healthcare solutions company, today announced financial results for the third quarter and nine months ended September 30, 2024. Third Quarter 2024 Highlights* All comparisons are to the quarter ended September 30, 2023, unless otherwise noted Total bookings of $21.0 million compared to $15.0 million Total revenue of $83.8 million compared to $82.7 million Financial Health revenue of $54.3 million compared to $46.6 million Financial Health revenue represented 64.7% of TruBridge's total revenue GAAP (loss) earnings per diluted share of $(0.66) compared to $(0.24) Non-GAAP (loss) earnings per diluted share of $(0.21) compared to $0.45 GAAP net
TruBridge (NASDAQ:TBRG), a healthcare solutions company, today announced that it will release its financial results for the third quarter ended September 30, 2024, on Thursday, November 7, 2024, after the market closes. The Company will host a conference call at 8:00 a.m. Central Time, 9:00 a.m. Eastern Time on Friday, November 8, 2024. To access this interactive teleconference, dial (877) 407-0890 and request connection to the TruBridge earnings conference call. A live broadcast of TruBridge's conference call will also be available online at the Company's website, www.trubridge.com. The 30-day online replay will be available approximately an hour following the conclusion of the live broad
TruBridge, Inc. (NASDAQ:TBRG), a healthcare solutions company, today announced financial results for the second quarter ended June 30, 2024. Second Quarter 2024 Highlights All comparisons are to the quarter ended June 30, 2023, unless otherwise noted Total bookings of $23.3 million compared to $21.0 million Total revenue of $84.7 million compared to $84.6 million Revenue Cycle Management (RCM) revenue of $54.1 million compared to $47.8 million RCM revenue represented 63.9% of TruBridge's total revenue GAAP (loss) earnings per diluted share of $(0.34) compared to $(0.20) Non-GAAP earnings per diluted share of $0.16 compared to $0.40 Adjusted EBITDA of $12.6 million
4 - TruBridge, Inc. (0001169445) (Issuer)
4 - TruBridge, Inc. (0001169445) (Issuer)
4 - TruBridge, Inc. (0001169445) (Issuer)
4 - TruBridge, Inc. (0001169445) (Issuer)
3 - TruBridge, Inc. (0001169445) (Issuer)
4 - TruBridge, Inc. (0001169445) (Issuer)
Veteran P&C Insurance Analytics Leader Brings Deep Expertise to Guidewire's Board of Directors Guidewire (NYSE:GWRE) today announced that it appointed Mark Anquillare to its Board of Directors effective September 23, 2024. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240925715389/en/Mark Anquillare joins Guidewire Software's Board of Directors. (Photo: Business Wire) "We are thrilled to welcome Mark Anquillare to the Guidewire Board of Directors. With Guidewire Cloud Platform now established as the trusted platform used by P&C insurers globally, we are uniquely positioned to further embed data, analytics, and AI throughout ins
TruBridge, Inc. (NASDAQ:TBRG), a healthcare solutions company, today announced that management will participate in the Stephens 2024 Annual Investment Conference to be held November 19-21, 2024, in Nashville, Tennessee. The fireside chat presentation by Chris Fowler, president and chief executive officer, and Vinay Bassi, chief financial officer, will begin at approximately 2:00 p.m. Central Time on Wednesday, November 20, 2024, and will be available to investors via a live audio webcast. A link to the webcast can be found at the investor relations section of the Company's website www.trubridge.com. About TruBridge We are a trusted partner to more than 1,500 healthcare organizations w
TruBridge, Inc. (NASDAQ:TBRG), a healthcare solutions company, today announced financial results for the third quarter and nine months ended September 30, 2024. Third Quarter 2024 Highlights* All comparisons are to the quarter ended September 30, 2023, unless otherwise noted Total bookings of $21.0 million compared to $15.0 million Total revenue of $83.8 million compared to $82.7 million Financial Health revenue of $54.3 million compared to $46.6 million Financial Health revenue represented 64.7% of TruBridge's total revenue GAAP (loss) earnings per diluted share of $(0.66) compared to $(0.24) Non-GAAP (loss) earnings per diluted share of $(0.21) compared to $0.45 GAAP net
TruBridge (NASDAQ:TBRG), a healthcare solutions company, today announced that it will release its financial results for the third quarter ended September 30, 2024, on Thursday, November 7, 2024, after the market closes. The Company will host a conference call at 8:00 a.m. Central Time, 9:00 a.m. Eastern Time on Friday, November 8, 2024. To access this interactive teleconference, dial (877) 407-0890 and request connection to the TruBridge earnings conference call. A live broadcast of TruBridge's conference call will also be available online at the Company's website, www.trubridge.com. The 30-day online replay will be available approximately an hour following the conclusion of the live broad
SC 13G/A - TruBridge, Inc. (0001169445) (Subject)
SC 13D/A - TruBridge, Inc. (0001169445) (Subject)
SC 13G/A - TruBridge, Inc. (0001169445) (Subject)
RBC Capital Mkts initiated coverage of TruBridge with a rating of Outperform and set a new price target of $13.00
10-Q - TruBridge, Inc. (0001169445) (Filer)
8-K - TruBridge, Inc. (0001169445) (Filer)
8-K - TruBridge, Inc. (0001169445) (Filer)